Nippon India Pharma Fund
Empty
1–7 yearsInvestment Horizon
Empty
Empty
Performance and Risk Analysis
Historical returns, volatility patterns, and how this fund has performed relative to its benchmark.
Risk Profile
Standard Deviation18.0%
Sharpe Ratio0.57
Beta0.91
Strategy Details
A closer look at the investment thesis, portfolio construction, and current holdings.
Portfolio Holdings Overview
SectoralAllocation
Geographic Allocation
Domestic100%
Top Stock Holdings
CompanySectorAllocation
Sun Pharmaceuticals Industries LtdServices12.57%
Divi's Laboratories LtdServices9.49%
Lupin LtdServices5.82%
Cipla LtdServices5.62%
Dr Reddy's Laboratories LtdServices5.49%
Apollo Hospitals Enterprise LtdServices5.34%
Medplus Health Services LtdServices4.20%
GlaxoSmithKline Pharmaceuticals LtdServices3.73%
Vijaya Diagnostic Centre LtdServices3.24%
Narayana Hrudayalaya LtdServices2.94%
Operational & Regulatory Details
What it costs to invest, transaction mechanics, and regulatory disclosures you should know.
Costs and Fees
Total Expense Ratio (TER)1.8%
Exit Load1
Regulatory & Tax Information
INF204K01968
ISINDailyDealing Frequency
BSE Healthcare PRBenchmark
LTCG | >1Year 12.5%% on gain above 1.25 Lakh
STCG | <1Year 20%%
Tax Implications (India)